ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

BioNTech Eyes Cancer Vaccines by 2030

The company behind one of the most successful COVID-19 vaccines wants to use their mRNA technology to take on cancer.

Bbc
BBC

BioNtech and Pfizer teamed up for one of the most successful vaccination campaigns in history. Now, according to a recent Interesting Engineering article, BioNTech says it has made breakthroughs that could lead to cancer vaccines in the near future. Professors Uğur Şahin and Özlem Türeci, the husband and wife team behind BioNTech, believe the mRNA technology used for their COVID-19 vaccine could be tweaked to make the immune system attack cancer cells rather than coronaviruses as soon as 2030.

The company is working to create treatments for a range of cancers including bowel cancer and melanoma. However, cancer cells that make up tumors can contain a wide variety of different proteins, which make them hard to target without attacking healthy surrounding tissue. 

Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub